Numed Laboratories Private Limited
About Numed Laboratories Private Limited
Data last updated:
Numed Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1988PTC049678. Its GSTIN is 27AAACN1759N1Z2 (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Suresh Lalchand Bafna and Mukesh Kumar Bafna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 801 C Valencia Tower T J Marg Tardeo Road, Mumbai, Maharashtra, India – 400007.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹3.63 Lakh (net margin 1.6%) and EBITDA of ₹4.66 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Numed Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address801 C Valencia Tower T J Marg Tardeo Road, Mumbai, Maharashtra, India – 400007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Numed Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Numed Laboratories is manufacturing. In detail, this covers printing and reproduction of recorded media.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 18 | Printing and reproduction of recorded media |
To see the full business activity and turnover split of Numed Laboratories Private Limited, buy the company report.
Financials of Numed Laboratories Private Limited
FY 2025 filings availableNumed Laboratories Private Limited reported revenue of ₹2.22 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Numed Laboratories Private Limited, buy the company report.
Board of directors of Numed Laboratories Private Limited
Numed Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Lalchand Bafna | Director | 18 Nov 1988 | 37 Years 11 Months | Current |
| Mukesh Kumar Bafna | Director | 18 Nov 1988 | 37 Years 11 Months | Current |
Auditor
Numed Laboratories Private Limited is audited by VIJAY JOGANI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY JOGANI & CO | FY 2021 | 111409W |
Shareholding
The shareholding of Numed Laboratories Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Numed Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Numed Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Numed Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Numed Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN1759N1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Numed Laboratories Private Limited, buy the company report.
Recent activity
Numed Laboratories Private Limited has 2 board changes on record since 1988: 2 appointments. The latest: Mukesh Kumar Bafna was appointed as Director on 18 Nov 1988.
Frequently asked questions
Numed Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 1988 (38+ years old) and is registered under CIN U24230MH1988PTC049678.
Numed Laboratories has 2 current directors:
- Suresh Lalchand Bafna - Director
- Mukesh Kumar Bafna - Director
The latest financial statements of Numed Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Numed Laboratories is 27AAACN1759N1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Numed Laboratories is U24230MH1988PTC049678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Numed Laboratories was incorporated on 18 November 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.
Mukesh Kumar Bafna was appointed as Director on 18 Nov 1988. Suresh Lalchand Bafna was appointed as Director on 18 Nov 1988.
The registered office of Numed Laboratories is at 801 C Valencia Tower T J Marg Tardeo Road, Mumbai, Maharashtra, India – 400007.
Numed Laboratories operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Numed Laboratories is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.